Tocilizumab reduces hypercoagulation in COVID-19 - Perspectives from the coagulation and immunomodulation Covid assessment (Coag-ImmCovA) clinical trial.
Almskog LM, Sjöström A, Sundén-Cullberg J, Taxiarchis A, Ågren A, Freyland S, Börjesson M, Wikman A, Wahlgren CM, Wanecek M, van der Linden J, Antovic J, Lampa J, Magnusson M.
Almskog LM, et al. Among authors: wikman a.
Thromb Res. 2024 Nov;243:109135. doi: 10.1016/j.thromres.2024.109135. Epub 2024 Aug 30.
Thromb Res. 2024.
PMID: 39226747
Free article.
Clinical Trial.